Proepithelin is a secreted pluripotent growth factor that plays a significant role in cell proliferation and cell cycle progression in many cellular systems. Proepithelin is highly expressed in several aggressive tumors and it is also promoting cell migration, wound healing and tissue repair. Despite the strong connections with growth control and cancer, proepithelin 's mode of action is not well understood. Furthermore, the proepithelin receptor and/or proteins that mediate the early stages of proepithelin signaling from the plasma membrane have not been identified. The objective of this grant proposal is to elucidate the molecular mechanism(s) by which proepithelin promotes proliferation and migration of bladder cells. The central hypothesis of this application is that proepithelin plays a critical role in cell growth, migration and transformation of bladder cells. Our hypothesis is based on our preliminary findings, which indicates that proepithelin promotes proliferation and migration of bladder cells. We have also identified a novel proepithelin-interacting transmembrane protein that we hypothesized is the proepithelin receptor. ? We will test our hypothesis and accomplish the objectives of this application through the following specific aims: ? ? Characterize the mechanism(s) that regulates proepithelin signaling in bladder cells ? ? Investigate how the proepithelin receptor affects proepithelin signaling in bladder cells ? ? Investigate the role of proepithelin in human bladder cancer. ? To address these specific aims this grant application proposes experiments focusing on normal and cancer urothelial cells. We will use small interfering RNA (siRNA), over-expression and dominant negative approaches to investigate the function of proepithelin and the proepithelin receptor in urothelial cells. A combination of assays for proliferation and migration and assays for proepithelin-dependent signal transduction will be employed. The significance of this grant proposal is not only in terms of a better knowledge of proepithelin action in the biology of bladder cells, but in the long range this studies could yield valuable information for translational research. Given the critical role of proepithelin in malignant transformation, it may prove a useful clinical target for prognosis and therapy. Furthermore, the identification of novel proteins and novel mechanism(s) that regulate proepithelin action will help us in designing novel therapeutic agents to target malignant cells in bladder tumors. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK068419-04
Application #
7404445
Study Section
Tumor Cell Biology Study Section (TCB)
Program Officer
Hoshizaki, Deborah K
Project Start
2005-05-01
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
4
Fiscal Year
2008
Total Cost
$243,501
Indirect Cost
Name
Thomas Jefferson University
Department
Urology
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Genua, Marco; Xu, Shi-Qiong; Buraschi, Simone et al. (2012) Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells. PLoS One 7:e40148
Morcavallo, Alaide; Genua, Marco; Palummo, Angela et al. (2012) Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A. J Biol Chem 287:11422-36
Fassan, Matteo; D'Arca, Domenico; Letko, Juraj et al. (2011) Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. PLoS One 6:e19771
Iozzo, Renato V; Buraschi, Simone; Genua, Marco et al. (2011) Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem 286:34712-21
Metalli, David; Lovat, Francesca; Tripodi, Farida et al. (2010) The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Am J Pathol 176:2997-3006
Lovat, Francesca; Bitto, Alessandro; Xu, Shi-Qiong et al. (2009) Proepithelin is an autocrine growth factor for bladder cancer. Carcinogenesis 30:861-8
Vecchione, A; Fassan, M; Anesti, V et al. (2009) MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer. Oncogene 28:257-69
Monami, Giada; Emiliozzi, Velia; Bitto, Alessandro et al. (2009) Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol 174:1037-47
Monami, Giada; Gonzalez, Eva M; Hellman, Michelle et al. (2006) Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. Cancer Res 66:7103-10